Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
2021 · Targeted Oncology · 32 citations
https://doi.org/10.1007/s11523-021-00795-5
G
Giorgio Patelli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
759
Citations
12
h-index
16
i10-index
Giorgio Patelli is an academic researcher from University of Milan. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer. The author has an h-index of 12, co-authored 32 publications.
ORCID: 0000-0001-8697-2158Papers by this author
worksThe predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review
2022 · Cancer Treatment Reviews · 22 citations
https://doi.org/10.1016/j.ctrv.2022.102488
Tumor “age” in early-onset colorectal cancer
2025 · Cell · 21 citations
https://doi.org/10.1016/j.cell.2024.12.003
Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review
2025 · Cancer Treatment Reviews · 9 citations
https://doi.org/10.1016/j.ctrv.2025.102908
Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report
2023 · World Journal of Surgical Oncology · 4 citations
https://doi.org/10.1186/s12957-023-02976-0
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies
2025 · Drugs · 4 citations
https://doi.org/10.1007/s40265-025-02253-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat